Related Experiment Videos
[Initial plasmapheresis treatment results in glomerulonephritis]
Vutreshni Bolesti
|January 1, 1981
Summary
Plasmapheresis combined with immunosuppressants improved glomerulonephritis in two patients. This treatment reduced immunoglobulins and increased serum complement, showing promise for active nephritis forms.
Area of Science:
- Nephrology
- Immunology
Background:
- Glomerulonephritis presents complex therapeutic challenges.
- Systemic lupus erythematosus can cause severe nephritis.
Observation:
- Two patients with glomerulonephritis (exacerbated nephritis and lupus nephritis) were treated.
- Treatment involved plasmapheresis, corticosteroids, and cytostatic agents.
Findings:
- Plasmapheresis led to reduced plasma immunoglobulins.
- Serum complement levels increased post-treatment.
- Clinical improvement was observed in both patients.
Implications:
- Plasmapheresis shows potential as an active therapy for severe glomerulonephritis.
- This approach may offer benefits in managing autoimmune kidney diseases.
- Further research into plasmapheresis for nephritis is warranted.